- September 13, 2012
Penn Medicine Research Team Honored with John Scott Award from the Board of Directors of City Trusts
Virginia M.Y. Lee, PhD, MBA, and John Q. Trojanowski, MD, PhD, both professors of Pathology and Laboratory Medicine at the Perelman School of Medicine at the University of Pennsylvania, have received the John Scott Award and $12,000 for their contribution to research in the treatment of neurodegenerative diseases.
"It is our great pleasure at the Board of Directors of City Trusts to honor these distinguished winners and applaud their extraordinary achievements in science and medicine," said Hon. Ronald R. Donatucci, President of The Board of Directors of City Trusts. "The John Scott Award is given to 'the most deserving men and women for their outstanding contributions to mankind.' Clearly, as world renowned leaders in their field, they have epitomized the purpose of the award."
The donor, John Scott, was an Edinburgh chemist, who in the early 1800s set up a fund to award "ingenious men or women who make useful inventions." The Board of Directors of City Trusts is charged with the administration of 115 trusts left to the City of Philadelphia for charitable purposes.
Lee and Trojanowski, both professional and personal partners, are co-directors of the Center for Neurodegenerative Disease Research (CNDR). Among other roles, Lee is the John H. Ware 3rd Professor in Alzheimer's Research and co-director of the Marian S. Ware Alzheimer Drug Discovery Program. Trojanowski is also director of the Institute on Aging and the William Maul Measey-Truman G. Schnabel, Jr. MD Professor of Geriatric Medicine and Gerontology.
The Board of City Trusts will acknowledge Lee and Trojanowski at a reception at the American Philosophical Society in November.
Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $4.3 billion enterprise.
The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 17 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $392 million awarded in the 2013 fiscal year.
The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania -- recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; Chester County Hospital; Penn Wissahickon Hospice; and Pennsylvania Hospital -- the nation's first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Chestnut Hill Hospital and Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2013, Penn Medicine provided $814 million to benefit our community.